TRNT1 and breast cancer: We used 2 different types of breast cancer cells to evaluate the antimigration activities of CCA-1.1, as these subtypes promote aggressive tumor growth, lead to malignant cell migration and invasion, and mediate metastasis, resulting in poor prognosis; all of these with their distinct mechanisms and pathways (Rakha and Chan, 2011).